Matt Henriksen

But how about a quick summary?

Because that 30 years of experience probably has been able to help you navigate some of these FDA pathways, these clinical pathways a little bit better.

better than you may would have in the beginning of your career.

So what were your steps to getting there?

And kind of, was there any one or two experiences that really helped you with this role?

Well, I'm assuming that you're referring to like the guidance time.

Yeah, and it's just so fascinating because of, with Boston's track record the last few years of minimizing those mistakes, of successfully integrating key acquisitions and things like that, that you forget that they had that period where they weren't as efficient back then.

That's right.

It's kind of,

Let me ask you this.

Is there something where, was there one key change there at your time?

Was there kind of, you know, a new playbook that was applied to these things that kind of changed that kind of, let's not say luck, but that, you know, being less efficient to being more efficient?

Or was it just, you know, a change in just, you know, the...

Yeah, that's actually really fascinating to see that trend throughout the years.

And I apologize to you and to the listeners for digressing so much.

Let's go back to PowerPAD2.

So you had the feasibility work done.

You did the record, not record time, but very fast FDA approval to get the IDE started.

We have the enrollment.

Data came out last November at Viva.